COVID-19 Vaccine Progress and Predicaments

Kristen Marks, MD
Associate Professor of Medicine / Clinical Trials Unit Co-Director
Division of Infectious Disease / Weill Cornell Medical College
New York, NY

Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2021. All rights reserved.



CME VIDEOTop of page

How to Obtain CME Credit:Top of page

About the Presenter:Top of page

Dr. Marks is an Associate Professor of Medicine at Weill Cornell Medicine where she conducts clinical trials related to HIV, HCV and COVID prevention and treatment. She serves as a co-director of the Cornell HIV/AIDS Clinical Trials Unit, where she conducts several treatment studies related to HIV and hepatitis viruses. She served as co-chair of IDSA/AASLD’s joint guidelines panel for “Recommendations for testing, managing and treating hepatitis C” and as a member of New York State’s HCV guidelines panel. When the COVID pandemic hit New York City, she led the phase 3 studies of remdesivir at Weill Cornell and continues to lead the phase 3 studies of vaccines for the prevention of COVID at Weill Cornell.

Learning Objectives: Top of page

At the completion of this educational session, participants will:
1) Know about vaccines under investigation and those available under EUA for prevention of COVID-19 illness.
2) Understand evidence for and against the use of booster doses at this time.
3) Be aware of adverse events of these vaccines and common vaccine management questions.

CME Information:Top of page


This CME activity has approved for AMA PRA Category 1 Credit™ for September 22, 2021 as a live activity.  This activity will also be available as an enduring activity from September 23, 2021, through Sept 21, 2024.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:Top of page


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.

- Dr. James F. Braun, DO (Course Director) has no relevant financial relationships to disclose.

- Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose.

- Dr. Kristen Marks (Presenter) has no relevant financial relationships to disclose. Dr. Marks will support her presentation and clinical recommendations with the best available evidence from the medical literature, and will submit her slides in advance for adequate peer review.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

How to Obtain CME Credit:Top of page

Click here to take the CME Evaluation and Post-Meeting Evaluation

You must be logged in to post a comment. Login | Register